After eight years working in biotech business development in San Francisco, Dr Jamie Love returned to use his skills and experience at the Division of Pathway Medicine.
These are excerpts from an interview with Talent Scotland.
What exactly does your role entail?
My job is to look at business opportunities for the Division of Pathway Medicine’s core research programmes.
What brought you to Scotland in the first place?
I first worked in Scotland in 1990 where, after receiving my PhD in Biochemistry and Molecular Biology from the University of Louisiana, I decided to do my first Post-Doctorate at the Roslin Institute in Edinburgh.
I originally came for two years, but stayed for 10! That’s because I met my future wife, Christine, who was also working at the Roslin Institute at the time. I only returned to the US when Christine was offered a job in California.
What tempted you back to Scotland?
Although my job here is only a short-term contract, I am very excited about what is happening in Scotland, especially with the development of the BioQuarter.
You’ve got big players, such as the NHS and the University, coming together to create critical mass. You’ll have clinicians working alongside scientists - it’s a researcher’s dream and full of potential opportunities!
I have seen similar BioQuarters in San Francisco’s Bay Area and in Seattle. However, as Scotland is starting from a much smaller scale, I see enormous opportunities - not just for me in future job prospects, but also for the sector as a whole.
You obviously like living in Scotland - what is the appeal?
I love all the usual things about Scotland - the wonderful countryside, the friendly people, living in the village of Roslin and being able to enhance my green credentials by commuting to work by bus!
I also believe that the UK has more ‘social awareness’ than the US. I feel that people in Scotland are on a more even keel than the US and here there are support structures for those in society that need help. In the US there is a huge difference between the rich and the poor.
Professionally, it’s great to use my experience in a country where it is appreciated and where I can really feel I’m making a difference to the University and Scotland’s bioscience sector as a whole.
This article was published on Jun 15, 2010